115 related articles for article (PubMed ID: 6096242)
1. [Studies on the synthesis of Epstein-Barr virus-related antigens induced by superinfection].
Fujiwara S
Hokkaido Igaku Zasshi; 1984 Sep; 59(5):586-602. PubMed ID: 6096242
[TBL] [Abstract][Full Text] [Related]
2. Multiplicity-dependent induction of viral capsid antigen in Raji cells superinfected with Epstein-Barr virus.
Fujiwara S; Takada K; Yano S; Osato T
Virology; 1983 Jul; 128(2):490-4. PubMed ID: 6310870
[TBL] [Abstract][Full Text] [Related]
3. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM
J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
[TBL] [Abstract][Full Text] [Related]
4. A novel early antigen associated with Epstein-Barr virus productive cycle.
Freemer CS; Bertoni G; Takagi S; Sairenji T
Virology; 1993 May; 194(1):387-92. PubMed ID: 8386883
[TBL] [Abstract][Full Text] [Related]
5. Induction of Epstein-Barr virus antigens by hydroxyurea.
Nováková Z; Roubal J
Acta Virol; 1988 Mar; 32(2):160-3. PubMed ID: 2899964
[TBL] [Abstract][Full Text] [Related]
6. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns.
Klein G; Zeuthen J; Ber R; Ernberg I
J Natl Cancer Inst; 1982 Feb; 68(2):197-202. PubMed ID: 6278188
[TBL] [Abstract][Full Text] [Related]
7. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
[TBL] [Abstract][Full Text] [Related]
8. An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivo.
Edson CM; Cohen LK; Henle W; Strominger JL
J Immunol; 1983 Feb; 130(2):919-24. PubMed ID: 6294181
[TBL] [Abstract][Full Text] [Related]
9. Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines.
Gerber P; Ablashi D; Magrath I; Armstrong G; Andersen P; Trach L
J Natl Cancer Inst; 1982 Sep; 69(3):585-90. PubMed ID: 6287082
[TBL] [Abstract][Full Text] [Related]
10. Effect of indomethacin on Epstein-Barr virus early antigen induction.
Daniel LW; Bauer G; zur Hausen H
Cancer Res; 1984 Mar; 44(3):981-3. PubMed ID: 6318991
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus (EBV) replication and expressions of EA-D (BMRF1 gene product), virus-specific deoxyribonuclease, and DNA polymerase in EBV-activated Akata cells.
Daibata M; Sairenji T
Virology; 1993 Oct; 196(2):900-4. PubMed ID: 8396819
[TBL] [Abstract][Full Text] [Related]
12. [Studies on Epstein-Barr virus strain differences with monoclonal antibodies].
Yang ZH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Feb; 11(1):41-5. PubMed ID: 2548745
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
14. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of D and R components of Epstein-Barr virus early antigen after superinfection and after induction with 5-iododeoxyuridine.
Simonová I; Závadová H; Vonka V
Acta Virol; 1977 May; 21(3):184-8. PubMed ID: 18915
[TBL] [Abstract][Full Text] [Related]
16. Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection.
Bhaduri-McIntosh S; Landry ML; Nikiforow S; Rotenberg M; El-Guindy A; Miller G
J Infect Dis; 2007 Feb; 195(4):483-92. PubMed ID: 17230407
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the expression of Epstein-Barr virus antigens in vitro by Chinese medicine compound "Dongxia wan".
Huang P; Deng H; Zhao M
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Jun; 14(2):128-30. PubMed ID: 11503041
[TBL] [Abstract][Full Text] [Related]
18. Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).
Klein G; Zeuthen J; Eriksson I; Terasaki P; Bernoco M; Rosén A; Masucci G; Povey S; Ber R
J Natl Cancer Inst; 1980 Apr; 64(4):725-38. PubMed ID: 6245297
[TBL] [Abstract][Full Text] [Related]
19. A major DNA binding protein encoded by BALF2 open reading frame of Epstein-Barr virus (EBV) forms a complex with other EBV DNA-binding proteins: DNAase, EA-D, and DNA polymerase.
Zeng Y; Middeldorp J; Madjar JJ; Ooka T
Virology; 1997 Dec; 239(2):285-95. PubMed ID: 9434720
[TBL] [Abstract][Full Text] [Related]
20. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]